Elsiglutide is a pharmaceutical peptide used in the biomedical industry to manage type 2 diabetes and obesity. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, helping to regulate blood sugar levels and promote weight loss. Elsiglutide’s mechanism of action includes increasing insulin release, reducing glucagon secretion, and slowing gastric emptying, resulting in improved glycemic control and decreased appetite.
CAT# | R2022 |
CAS | 914009-84-0 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
C 21 is a kind of selective protein arginine methyltransferase 1 (PRMT1) inhibitor (IC50 = 1.8 μM). And it exhib ...
Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...
Sinapultide (also known as KL4 peptide) is a synthetic protein used to mimic human SP-B. Respiratory distress ...
The voltage-gated Kv1.3 channel in effector memory T cells serves as a new therapeutic target for multiple scler ...
The factors of skin aging The skin is one of the largest organs of the body. In many cases, as the person's age changes, the ...